CAM
Cormorant Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5M | Sell |
400,000
-200,000
| -33% | -$5.75M | 0.86% | 25 |
|
|
2025
Q1 | $20.1M | Sell |
600,000
-400,000
| -40% | -$13.4M | 1.51% | 21 |
|
|
2024
Q4 | $51.1M | Sell |
1,000,000
-100,000
| -9% | -$5.11M | 2.81% | 9 |
|
|
2024
Q3 | $56.2M | Sell |
1,100,000
-250,000
| -19% | -$12.8M | 2.98% | 8 |
|
|
2024
Q2 | $60.5M | Buy |
1,350,000
+200,000
| +17% | +$8.96M | 3.49% | 8 |
|
|
2024
Q1 | $53.8M | Hold |
1,150,000
| – | – | 2.36% | 11 |
|
|
2023
Q4 | $40.9M | Buy |
1,150,000
+48,096
| +4% | +$1.71M | 1.95% | 15 |
|
|
2023
Q3 | $32.8M | Buy |
+1,101,904
| New | +$32.8M | 1.91% | 14 |
|